
Metabolomics: Technologies and Global Markets
Description
Metabolomics: Technologies and Global Markets
Report Scope
This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.
Report Includes
32 data tables and 39 additional tables
An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
A look at ESG trends
Information on developments in R&D, clinical trials, emerging technologies, and economic trends
Analysis of key companies’ market shares, proprietary technologies, patents, and alliances
Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA
Companies Mentioned
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
DANAHER CORP.
MERCK KGAA
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.
Table of Contents
99 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Chapter 2 Market Overview
- Overview
- Overview of Metabolomics
- Separation Techniques
- Detection Techniques
- Metabolites and Their Applications
- R&D and Regulatory Approval
- Supply Chain Analysis
- Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Technological Advancements
- Increasing Healthcare Expenditure
- Expanding Applications Across Industries
- Market Restraints
- High Cost of Instruments and Services
- Complexity of Data Analysis
- Standardization and Quality Control Challenges
- Limited Biomarker Validation and Clinical Utility
- Market Opportunities
- Precision Medicine and Personalized Healthcare
- Drug Discovery and Development
- Biomarker Discovery and Validation
- Nutritional Profiling and Functional Foods
- Environmental Monitoring and Toxicology
- Market Challenges
- Data Complexity and Interpretation
- Standardization and Quality Assurance
- Biomarker Validation and Clinical Translation
- Technological Limitations and Costs
- Regulatory and Ethical Considerations
- Chapter 4 Emerging Technologies and Developments
- Introduction
- Clinical Trial Analysis
- By Study Type
- By Status
- By Gender
- By Interventions
- Granted Patents
- Introduction
- Patent Analysis
- Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Metabolomics Market, by Product
- Global Market Analysis and Forecast
- Separation Techniques
- Detection Techniques
- Metabolomics Market, by Indication
- Global Market Analysis and Forecast
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Other Diseases Indication
- Metabolomics Market, by Application
- Global Market Analysis and Forecast
- Biomarker Discovery
- Drug Discovery
- Toxicology Testing
- Nutrigenomics
- Functional Genomics
- Others
- Geographic Breakdown
- Metabolomics Market, by Region
- Global
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 6 Competitive Intelligence
- Company Share Analysis
- Strategic Analysis
- Mergers and Acquisitions
- Venture Capital Funding
- Chapter 7 Appendix
- Methodology
- Sources
- Acronyms
- Definitions/Taxonomy
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BIO-RAD LABORATORIES INC.
- BRUKER
- DANAHER CORP.
- MERCK KGAA
- SHIMADZU CORP.
- THERMO FISHER SCIENTIFIC INC.
- WATERS CORP.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.